Patent Prosecution Update
Patent Reform Continues to Focus on
Congress’s long-running efforts toward a compromise on patent reform legislation took another turn last month. On March 4, the Senate Judiciary Committee released an amendment to that legislation. The amendment replaces the bill approved by the Committee on April 2, 2009, without requiring any further Committee action. More
On February 19, 2010, an Enlarged Board of Appeals (Board) at the European Patent Office (EPO) concluded that Swiss-style claims will no longer be acceptable at the EPO. Prior to the Board’s decision, two types of medical-use claims were accepted by the EPO. The first and broadest type—the first medical-use claim—typically took the following form: “compound [X] for use as a medicament.” More
DISCLAIMER: The information contained herein is intended to convey general information only and should not be construed as a legal opinion or as legal advice. The firm disclaims liability for any errors or omissions and readers should not take any action that relies upon the information contained in this newsletter. You should consult your own lawyer concerning your own situation and any specific legal questions. This promotional newsletter does not establish any form of attorney-client relationship with our firm or with any of our attorneys.
Washington, DC • Atlanta, GA • Cambridge, MA • Palo Alto, CA • Reston, VA • Brussels • Shanghai • Taipei • Tokyo
Copyright © 2010 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP | All rights reserved